首页> 外文期刊>International journal of surgical pathology >Ossifying fibromyxoid tumor may express CD56 and CD99: a case report.
【24h】

Ossifying fibromyxoid tumor may express CD56 and CD99: a case report.

机译:骨化性纤维瘤样肿瘤可能表达CD56和CD99:一例病例报告。

获取原文
获取原文并翻译 | 示例
           

摘要

Ossifying fibromyxoid tumor (OFMT) is an uncommon soft tissue neoplasm characterized by a combination of myxoid and/or fibrous stroma with areas of ossification. Although most authors postulate a neuroectodermal origin for this peculiar tumor, there is no agreement in the literature regarding its histogenesis. In this article, we present the immunohistochemical findings of a case of a 39-year-old white male with an OFMT of the soft tissue in the mandibular region. The tumor was positive to S-100 protein, glial fibrillary acidic protein, CD99, CD56 and negative to smooth muscle actin, cytokeratins AE1/AE3, epithelial membrane antigen, and CD68. To the best of our knowledge, this is the first case reported to be positive to CD56 and CD99. Immunoreactivity to these two antibodies, together with reactivity for S-100 protein and glial fibrillary acidic protein, suggests that OFMT is of a neuroectodermal origin. In our opinion, in the absence of reactivity to at least one neuroectodermal marker one should seriously question a diagnosis of OFMT.
机译:骨化性纤维粘液样肿瘤(OFMT)是一种罕见的软组织肿瘤,其特征在于粘液样和/或纤维性基质与骨化区域相结合。尽管大多数作者都认为这种特殊肿瘤是神经外胚层起源,但有关其组织发生的文献尚无共识。在本文中,我们介绍了一例39岁的白人男性,其下颌区域软组织的OFMT的免疫组织化学结果。肿瘤对S-100蛋白,胶质纤维酸性蛋白,CD99,CD56呈阳性,对平滑肌肌动蛋白,细胞角蛋白AE1 / AE3,上皮膜抗原和CD68呈阴性。据我们所知,这是第一个对CD56和CD99呈阳性的病例。对这两种抗体的免疫反应性以及对S-100蛋白和神经胶质纤维酸性蛋白的反应性表明,OFMT是神经外胚层来源的。我们认为,在缺乏与至少一种神经外胚层标志物的反应性的情况下,应认真质疑OFMT的诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号